Cognex Corporation

05/07/2025 | Press release | Distributed by Public on 05/07/2025 14:07

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Moschner Matthew
2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [CGNX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President and COO
(Last) (First) (Middle)
ONE VISION DRIVE
3. Date of Earliest Transaction (Month/Day/Year)
05/05/2025
(Street)
NATICK, MA 01760
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3,812 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $27.99 05/05/2025 A 279,070 05/05/2029(1) 05/05/2035 Common Stock 279,070 $ 0 279,070 D
Non-Qualified Stock Option (right to buy) $32.78 02/21/2029 02/21/2035 Common Stock 76,924 76,924 D
Non-Qualified Stock Option (right to buy) $33.04 02/18/2026 02/18/2035 Common Stock 68,823 68,823 D
Non-Qualified Stock Option (right to buy) $39.44 02/20/2025 02/20/2034 Common Stock 58,260 58,260 D
Non-Qualified Stock Option (right to buy) $40.71 11/19/2019 11/19/2028 Common Stock 4,000 4,000 D
Non-Qualified Stock Option (right to buy) $42.84 10/31/2021 10/31/2028 Common Stock 7,000 7,000 D
Non-Qualified Stock Option (right to buy) $47.21 02/21/2024 02/21/2033 Common Stock 37,832 37,832 D
Non-Qualified Stock Option (right to buy) $47.95 08/04/2026 08/04/2032 Common Stock 35,639 35,639 D
Non-Qualified Stock Option (right to buy) $50.01 08/07/2027 08/07/2033 Common Stock 47,962 47,962 D
Non-Qualified Stock Option (right to buy) $51.49 02/19/2020 02/19/2029 Common Stock 4,000 4,000 D
Non-Qualified Stock Option (right to buy) $51.97 10/30/2020 10/30/2029 Common Stock 9,000 9,000 D
Non-Qualified Stock Option (right to buy) $56.44 02/20/2019 02/20/2028 Common Stock 1,600 1,600 D
Non-Qualified Stock Option (right to buy) $86.38 08/09/2025 08/09/2031 Common Stock 8,426 8,426 D
Restricted Stock Unit $ 0 08/04/2023 08/04/2025 Common Stock 3,441 3,441 D
Restricted Stock Unit $ 0 02/21/2024 02/21/2026 Common Stock 3,495 3,495 D
Restricted Stock Unit $ 0 08/07/2024 08/07/2026 Common Stock 7,999 7,999 D
Restricted Stock Unit $ 0 02/20/2025 02/20/2027 Common Stock 8,113 8,113 D
Restricted Stock Unit $ 0 02/18/2026 02/18/2028 Common Stock 25,424 25,424 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Moschner Matthew
ONE VISION DRIVE
NATICK, MA 01760
President and COO

Signatures

Matthew Moschner 05/07/2025
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The options vest approximately 50% on the fourth anniversary of the grant date (May 5, 2025) and 50% on the fifth anniversary of the grant date.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Cognex Corporation published this content on May 07, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on May 07, 2025 at 20:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io